Leukemic Phase of ALCL

• Conditions: Anaplastic Lymphoma

• Registration Number: NCT04908059
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

Collecting data about the rare leukemic presentation of anaplastic lymphoma to study the characteristics of patients with leukemic phase of ALCL

Detailed Description

Not available

Study Timeline

• Study Start: 2021-01-27
• Status Verified: 2021-05
• Study First Submitted: 2021-05-26
• Study First Submitted QC: 2021-05-26
• Study First Posted: 2021-06-01
• Last Update Submitted: 2021-07-07
• Last Update Posted: 2021-07-08
• Primary Completion: 2021-07-13
• Study Completion: 2021-07-13

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 2

Inclusion Criteria

• Patients presenting a leukemic phase of anaplastic lymphoma

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
A retrospective study of the diagnostic description of the leukemic phases of anaplastic lymphoma in real life	Files analysed retrospectively from January 01, 2020 to December 31, 2020 will be examined]

Trial Locations

Locations (1)

Hematology Laboratory - Strasbourg University Hospitals; 🇫🇷 Strasbourg, France